LGLSX
Price
$47.73
Change
+$0.55 (+1.17%)
Updated
Jun 2 closing price
Net Assets
6.88B
VIGRX
Price
$214.29
Change
+$1.43 (+0.67%)
Updated
Jun 2 closing price
Net Assets
269.26B
Interact to see
Advertisement

LGLSX vs VIGRX

Header iconLGLSX vs VIGRX Comparison
Open Charts LGLSX vs VIGRXBanner chart's image
Lord Abbett Growth Leaders R4
Price$47.73
Change+$0.55 (+1.17%)
VolumeN/A
Net Assets6.88B
Vanguard Growth Index Investor
Price$214.29
Change+$1.43 (+0.67%)
VolumeN/A
Net Assets269.26B
LGLSX vs VIGRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LGLSX vs. VIGRX commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGLSX is a Buy and VIGRX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 269B vs. LGLSX (6.88B). VIGRX pays higher dividends than LGLSX: VIGRX (0.35) vs LGLSX (0.00). LGLSX was incepted earlier than VIGRX: LGLSX (10 years) vs VIGRX (33 years). LGLSX (0.90) is less costly to investors than VIGRX (0.17). LGLSX is a more actively managed with annual turnover of: 94.00 vs. VIGRX (11.00). LGLSX has a lower initial minimum investment than VIGRX: LGLSX (0) vs VIGRX (3000). LGLSX annual gain was more profitable for investors over the last year : 23.86 vs. VIGRX (17.83). VIGRX return over 5 years is better than : 109.40 vs. LGLSX (39.17).
LGLSXVIGRXLGLSX / VIGRX
Total Expense Ratio0.900.17529%
Annual Report Gross Expense Ratio0.900.17529%
Fund Existence10 years33 years-
Gain YTD-0.1690.743-23%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets6.88B269B3%
Annual Yield % from dividends0.000.35-
Returns for 1 year23.8617.83134%
Returns for 3 years63.2070.0690%
Returns for 5 years39.17109.4036%
Returns for 10 yearsN/A281.42-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PMCB1.070.04
+4.35%
PharmaCyte Biotech
IKT2.050.04
+1.99%
Inhibikase Therapeutics
AC37.780.46
+1.23%
Associated Capital Group
GBDC15.14-0.07
-0.46%
Golub Capital BDC
CAG22.76-0.13
-0.57%
Conagra Brands